On this World Asthma Day, May 3, 2002, The Microbiome First – Pathway to Sustainable Healthcare Summit organization committee invites healthcare professionals, non-communicable disease community leaders, and stakeholders to participate in the inaugural Microbiome First Summit, a virtual event taking…
Asthma and Bacteria: Nose to the Toes
Staphylococcus aureus enterotoxins (intestinal toxins) have a demonstrated effect on airway disease including Asthma in early life according to multiple studies. These bacteria are in the gut and on the skin. To further the WAF misson to improve our understanding…
Asthma and Environmental Fungi – interview with Marie-Claire Arrieta Ph.D.
World Asthma Foundation “Defeating Asthma Series uncovers New Hope for Asthma Managementant Our understanding of Asthma and the way we treat it may soon be radically different from what currently exists, due to new research on the human microbiome and…
Asthma and Indoor Air Pollution:
Key insights for Asthmatics: Makes Asthma Worse Significant Association with Exacerbations Among this panel of relatively moderate to severe asthmatics, the respiratory irritants produced by several domestic combustion sources were associated with increased morbidity. Although there is abundant clinical evidence…
Gut Health and Asthma
The gut and lungs are anatomically distinct, but potential anatomic communications and complex pathways involving their respective microbiota have reinforced the existence of a gut–lung axis (GLA). Compared to the better-studied gut microbiota, the lung microbiota, only considered in recent…
Non-Eosinophilic Asthma (NEA)
Although non-eosinophilic asthma (NEA) is not the best known and most prevalent asthma phenotype, its importance cannot be underestimated. NEA is characterized by airway inflammation with the absence of eosinophils, subsequent to activation of non-predominant type 2 immunologic pathways. This…